Tofogliflozin decreases body fat mass and improves peripheral insulin resistance

Ren Matsuba1, Ikuro Matsuba2, Mototsugu Shimokawa3

  • 1Department of Internal Medicine, Division of Metabolism and Endocrinology, St Marianna University School of Medicine, Kanagawa, Japan.

Insights

Tofogliflozin, a sodium-glucose co-transporter-2 inhibitor, significantly improved insulin sensitivity and glucose uptake in type 2 diabetes patients. These benefits were linked to a reduction in body fat mass after 12 weeks of treatment.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by insulin resistance and impaired glucose metabolism.
  • Sodium-glucose co-transporter-2 (SGLT2) inhibitors represent a therapeutic class that enhances glucose excretion, potentially impacting systemic glucose handling.
  • Understanding the specific effects of SGLT2 inhibitors on peripheral glucose uptake is crucial for optimizing T2DM management.

Purpose of the Study:

  • To evaluate the impact of tofogliflozin, an SGLT2 inhibitor, on peripheral glucose uptake in patients with T2DM.
  • To assess changes in body composition, glucose metabolism, and other metabolic parameters following 12 weeks of tofogliflozin treatment.
  • To investigate the correlation between improvements in glucose uptake and changes in body fat mass.

Main Methods:

  • A single-arm, open-label study involving 16 patients with T2DM receiving dipeptidyl peptidase-4 inhibitor therapy.
  • Peripheral glucose uptake was measured using the hyperinsulinaemic-euglycaemic clamp technique (assessing M value and M/I ratio).
  • Key variables including body weight, blood pressure, glucose metabolism, liver function, lipid profile, and body composition were monitored before and after 12 weeks of tofogliflozin administration.

Main Results:

  • Tofogliflozin treatment for 12 weeks resulted in significant reductions in glycated haemoglobin, body weight, body fat mass, and lean body mass (P < .001).
  • Peripheral glucose uptake, a marker of insulin sensitivity, significantly increased (M value by 0.90, M/I ratio by 0.49; both P < .05).
  • The improvement in the M value was significantly correlated with the reduction in body fat mass (P < .05).

Conclusions:

  • Tofogliflozin effectively enhances insulin sensitivity and peripheral glucose uptake in patients with T2DM.
  • The observed improvements in glucose metabolism are significantly associated with a decrease in body fat mass.
  • These findings highlight a potential mechanism by which SGLT2 inhibition may benefit T2DM management beyond glycemic control.

Related Concept Videos

Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K
Decreasing Function01:27

Decreasing Function

A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
319
Reduced Mass Coordinates: Isolated Two-body Problem01:12

Reduced Mass Coordinates: Isolated Two-body Problem

In classical mechanics, the two-body problem is one of the fundamental problems describing the motion of two interacting bodies under gravity or any other central force. When considering the motion of two bodies, one of the most important concepts is the reduced mass coordinates, a quantity that allows the two-body problem to be solved like a single-body problem. In these circumstances, it is assumed that a single body with reduced mass revolves around another body fixed in a position with an...
2.4K
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
933
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.0K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K